Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 310 articles:
HTML format
Text format



Single Articles


    January 2018
  1. KONDILI LA, Gaeta GB, Ieluzzi D, Zignego AL, et al
    Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    PLoS One. 2018;13:e0190803.
    PubMed     Text format     Abstract available


  2. CHARRE C, Cotte L, Kramer R, Miailhes P, et al
    Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men.
    PLoS One. 2018;13:e0190340.
    PubMed     Text format     Abstract available


  3. CHEN SH, Lai HC, Chiang IP, Su WP, et al
    Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C.
    PLoS One. 2018;13:e0190455.
    PubMed     Text format     Abstract available


  4. LEE CS, Jung YJ, Kim SS, Cheong JY, et al
    Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.
    PLoS One. 2018;13:e0190261.
    PubMed     Text format     Abstract available


  5. CARIMO AA, Gudo ES, Maueia C, Mabunda N, et al
    First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique.
    PLoS One. 2018;13:e0190775.
    PubMed     Text format     Abstract available


  6. BIVIGOU-MBOUMBA B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, et al
    Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
    PLoS One. 2018;13:e0190592.
    PubMed     Text format     Abstract available


  7. FARSHADPOUR F, Taherkhani R, Ravanbod MR, Eghbali SS, et al
    Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran.
    PLoS One. 2018;13:e0191090.
    PubMed     Text format     Abstract available


  8. LEE HJ, Kim SJ, Kweon YO, Park SY, et al
    Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.
    PLoS One. 2018;13:e0190581.
    PubMed     Text format     Abstract available


  9. MAROT A, Dubois M, Trepo E, Moreno C, et al
    Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
    PLoS One. 2018;13:e0190823.
    PubMed     Text format     Abstract available


  10. OBIRI-YEBOAH D, Asante Awuku Y, Adu J, Pappoe F, et al
    Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana.
    PLoS One. 2018;13:e0191685.
    PubMed     Text format     Abstract available


  11. HEIL J, Hoebe CJPA, Loo IHMV, Cals JWL, et al
    Hepatitis E prevalence in a sexual high-risk population compared to the general population.
    PLoS One. 2018;13:e0191798.
    PubMed     Text format     Abstract available


  12. BOLOTIN S, Feld JJ, Garber G, Wong WWL, et al
    Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.
    PLoS One. 2018;13:e0191184.
    PubMed     Text format     Abstract available


  13. CHENG CH, Lin CC, Chen HL, Lin IT, et al
    Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection.
    PLoS One. 2018;13:e0191799.
    PubMed     Text format     Abstract available


  14. DEL CAMPO JA, Garcia-Valdecasas M, Gil-Gomez A, Rojas A, et al
    Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
    PLoS One. 2018;13:e0191805.
    PubMed     Text format     Abstract available


  15. NDJOYI-MBIGUINO A, Kombe Kombe AJ, Bivigou-Mboumba B, Zoa-Assoumou S, et al
    Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon.
    PLoS One. 2018;13:e0190529.
    PubMed     Text format     Abstract available


  16. SAFREED-HARMON K, Hetherington KL, Aleman S, Alho H, et al
    Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.
    PLoS One. 2018;13:e0190146.
    PubMed     Text format     Abstract available


  17. ZAHR NM
    Peripheral TNFalpha elevations in abstinent alcoholics are associated with hepatitis C infection.
    PLoS One. 2018;13:e0191586.
    PubMed     Text format     Abstract available


  18. DE PINA-ARAUJO IIM, Spitz N, Soares CC, Niel C, et al
    Hepatitis B virus genotypes A1, A2 and E in Cape Verde: Unequal distribution through the islands and association with human flows.
    PLoS One. 2018;13:e0192595.
    PubMed     Text format     Abstract available


  19. HUGHES E, Hopkins LJ, Parker R
    Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0192393.
    PubMed     Text format     Abstract available


  20. KELLY ML, Riordan SM, Bopage R, Lloyd AR, et al
    Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.
    PLoS One. 2018;13:e0192763.
    PubMed     Text format     Abstract available


  21. ANADOL E, Lust K, Boesecke C, Schwarze-Zander C, et al
    Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients.
    PLoS One. 2018;13:e0191118.
    PubMed     Text format     Abstract available


  22. RATTANAVIPAPONG W, Anothaisintawee T, Teerawattananon Y
    Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis.
    PLoS One. 2018;13:e0193112.
    PubMed     Text format     Abstract available


  23. TARAMASSO L, Di Biagio A, Bovis F, Nicolini LA, et al
    Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir +/- ribavirin in HIV/HCV co-infected patients.
    PLoS One. 2018;13:e0192627.
    PubMed     Text format     Abstract available


  24. AMBACHEW H, Zheng M, Pappoe F, Shen J, et al
    Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.
    PLoS One. 2018;13:e0193177.
    PubMed     Text format     Abstract available


  25. CHENG PN, Chiu YC, Chiu HC, Chien SC, et al
    The characteristics of residents with unawareness of hepatitis C virus infection in community.
    PLoS One. 2018;13:e0193251.
    PubMed     Text format     Abstract available


  26. MAPOURE NY, Budzi MN, Eloumou SAFB, Malongue A, et al
    Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2018;13:e0192406.
    PubMed     Text format     Abstract available


  27. BALSITIS S, Gali V, Mason PJ, Chaniewski S, et al
    Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.
    PLoS One. 2018;13:e0190058.
    PubMed     Text format     Abstract available


  28. MAUNOURY F, Clement A, Nwankwo C, Levy-Bachelot L, et al
    Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.
    PLoS One. 2018;13:e0194329.
    PubMed     Text format     Abstract available


  29. AN J, Kim JW, Shim JH, Han S, et al
    Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.
    PLoS One. 2018;13:e0193232.
    PubMed     Text format     Abstract available


  30. DI POTO C, He S, Varghese RS, Zhao Y, et al
    Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
    PLoS One. 2018;13:e0192748.
    PubMed     Text format     Abstract available


  31. MOTOYAMA H, Tamori A, Kubo S, Uchida-Kobayashi S, et al
    Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    PLoS One. 2018;13:e0194163.
    PubMed     Text format     Abstract available


  32. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    PubMed     Text format     Abstract available


  33. CARABALLO CORTES K, Rosinska M, Janiak M, Stepien M, et al
    Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.
    PLoS One. 2018;13:e0194816.
    PubMed     Text format     Abstract available


  34. SAUVAGE V, Boizeau L, Candotti D, Vandenbogaert M, et al
    Early MinION nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.
    PLoS One. 2018;13:e0194366.
    PubMed     Text format     Abstract available


  35. NEMOZ B, Roger L, Leroy V, Poveda JD, et al
    Evaluation of the cobas(R) GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures.
    PLoS One. 2018;13:e0194396.
    PubMed     Text format     Abstract available


  36. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Text format     Abstract available


  37. LI CW, Yang CJ, Sun HY, Tsai MS, et al
    Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.
    PLoS One. 2018;13:e0194149.
    PubMed     Text format     Abstract available


  38. BRAND RF, Rostal MK, Kemp A, Anyamba A, et al
    A phytosociological analysis and description of wetland vegetation and ecological factors associated with locations of high mortality for the 2010-11 Rift Valley fever outbreak in South Africa.
    PLoS One. 2018;13:e0191585.
    PubMed     Text format     Abstract available


  39. DES JARLAIS DC, Cooper HLF, Arasteh K, Feelemyer J, et al
    Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    PLoS One. 2018;13:e0194799.
    PubMed     Text format     Abstract available



  40. Retraction: rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2018;13:e0195181.
    PubMed     Text format    


  41. TI L, Socias ME, Wood E, Milloy MJ, et al
    The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
    PLoS One. 2018;13:e0194162.
    PubMed     Text format     Abstract available


  42. KHAN T, Zaman G, Saleh Alshomrani A
    Spreading dynamic of acute and carrier hepatitis B with nonlinear incidence.
    PLoS One. 2018;13:e0191914.
    PubMed     Text format     Abstract available


  43. YAMAZAKI T, Joshita S, Umemura T, Usami Y, et al
    Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
    PLoS One. 2018;13:e0195632.
    PubMed     Text format     Abstract available


  44. GOLIZEH M, Melendez-Pena CE, Ward BJ, Saeed S, et al
    Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
    PLoS One. 2018;13:e0195148.
    PubMed     Text format     Abstract available


  45. BELYHUN Y, Liebert UG, Maier M
    Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    PLoS One. 2018;13:e0191970.
    PubMed     Text format     Abstract available


  46. DE LA FUENTE C, Pinkham C, Dabbagh D, Beitzel B, et al
    Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.
    PLoS One. 2018;13:e0191983.
    PubMed     Text format     Abstract available


  47. EKO MBA JM, Bisseye C, Ntsame Ndong JM, Mombo LE, et al
    Prevalent hepatitis B surface antigen among first-time blood donors in Gabon.
    PLoS One. 2018;13:e0194285.
    PubMed     Text format     Abstract available


  48. HAN B, Yuan Q, Shi Y, Wei L, et al
    The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China.
    PLoS One. 2018;13:e0195455.
    PubMed     Text format     Abstract available


  49. FACENTE SN, Grebe E, Burk K, Morris MD, et al
    Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
    PLoS One. 2018;13:e0195575.
    PubMed     Text format     Abstract available


  50. FRIEDMAN A, Siewe N
    Chronic hepatitis B virus and liver fibrosis: A mathematical model.
    PLoS One. 2018;13:e0195037.
    PubMed     Text format     Abstract available


  51. HUGHES E, Hopkins LJ, Parker R
    Correction: Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0195857.
    PubMed     Text format     Abstract available


  52. LU Y, Jin X, Duan CA, Chang F, et al
    Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China.
    PLoS One. 2018;13:e0195117.
    PubMed     Text format     Abstract available


  53. HAMADA K, Saitoh S, Nishino N, Fukushima D, et al
    Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response.
    PLoS One. 2018;13:e0195173.
    PubMed     Text format     Abstract available


  54. MASHIBA T, Joko K, Kurosaki M, Ochi H, et al
    Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
    PLoS One. 2018;13:e0194704.
    PubMed     Text format     Abstract available


  55. FISHER KA, Cahill LM, Broyles S, Rorke M, et al
    Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use.
    PLoS One. 2018;13:e0196157.
    PubMed     Text format     Abstract available


  56. CHIU YM, Lai MS, Chan KA
    Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
    PLoS One. 2018;13:e0196210.
    PubMed     Text format     Abstract available


  57. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
    PLoS One. 2018;13:e0196301.
    PubMed     Text format     Abstract available


  58. OKUBO H, Ando H, Sorin Y, Nakadera E, et al
    Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C.
    PLoS One. 2018;13:e0196747.
    PubMed     Text format     Abstract available


  59. PARK H, Jeong D, Nguyen P, Henry L, et al
    Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
    PLoS One. 2018;13:e0196452.
    PubMed     Text format     Abstract available


  60. JIMENEZ-SOUSA MA, Gomez-Moreno AZ, Pineda-Tenor D, Medrano LM, et al
    The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
    PLoS One. 2018;13:e0197115.
    PubMed     Text format     Abstract available


  61. DEMSISS W, Seid A, Fiseha T
    Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia.
    PLoS One. 2018;13:e0196539.
    PubMed     Text format     Abstract available


  62. FENG Y, Feng YM, Wang S, Xu F, et al
    High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.
    PLoS One. 2018;13:e0197577.
    PubMed     Text format     Abstract available


  63. TSUKAMOTO Y, Ikeda S, Uwai K, Taguchi R, et al
    Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
    PLoS One. 2018;13:e0197664.
    PubMed     Text format     Abstract available


  64. MAWATARI S, Oda K, Tabu K, Ijuin S, et al
    The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.
    PLoS One. 2018;13:e0198642.
    PubMed     Text format     Abstract available


  65. YAMAMIYA D, Mizukoshi E, Kaji K, Terashima T, et al
    Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.
    PLoS One. 2018;13:e0198264.
    PubMed     Text format     Abstract available


  66. NAKANO T, Moriya K, Koike K, Horie T, et al
    Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0198345.
    PubMed     Text format     Abstract available


  67. BLANCO RY, Loureiro CL, Villalba JA, Sulbaran YF, et al
    Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela.
    PLoS One. 2018;13:e0197662.
    PubMed     Text format     Abstract available


  68. BRUNI R, Villano U, Equestre M, Chionne P, et al
    Hepatitis E virus genotypes and subgenotypes causing acute hepatitis, Bulgaria, 2013-2015.
    PLoS One. 2018;13:e0198045.
    PubMed     Text format     Abstract available


  69. GROTTENTHALER JM, Werner CR, Steurer M, Spengler U, et al
    Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.
    PLoS One. 2018;13:e0197544.
    PubMed     Text format     Abstract available


  70. MULLER SF, Konig A, Doring B, Glebe D, et al
    Characterisation of the hepatitis B virus cross-species transmission pattern via Na+/taurocholate co-transporting polypeptides from 11 New World and Old World primate species.
    PLoS One. 2018;13:e0199200.
    PubMed     Text format     Abstract available


  71. ZUCKERMAN A, Douglas A, Nwosu S, Choi L, et al
    Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era.
    PLoS One. 2018;13:e0199174.
    PubMed     Text format     Abstract available


  72. HAINSWORTH SW, Dietze PM, Wilson DP, Sutton B, et al
    Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas.
    PLoS One. 2018;13:e0198336.
    PubMed     Text format     Abstract available


  73. YEN YH, Kuo FY, Kee KM, Chang KC, et al
    APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.
    PLoS One. 2018;13:e0199760.
    PubMed     Text format     Abstract available


  74. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
    Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    PLoS One. 2018;13:e0199926.
    PubMed     Text format     Abstract available


  75. YAYA I, Roux P, Marcellin F, Wittkop L, et al
    Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    PLoS One. 2018;13:e0199874.
    PubMed     Text format     Abstract available


  76. KIM TH, Lee EJ, Choi JH, Yim SY, et al
    Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.
    PLoS One. 2018;13:e0199094.
    PubMed     Text format     Abstract available


  77. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Increased body fat percentage in patients with hepatitis B and C virus infection.
    PLoS One. 2018;13:e0200164.
    PubMed     Text format     Abstract available


  78. SCHAEFER B, Viveiros A, Al-Zoairy R, Blach S, et al
    Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030.
    PLoS One. 2018;13:e0200750.
    PubMed     Text format     Abstract available


  79. FACENTE SN, Grebe E, Burk K, Morris MD, et al
    Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
    PLoS One. 2018;13:e0200866.
    PubMed     Text format     Abstract available


  80. ZHERNAKOVA DV, Kliver S, Cherkasov N, Tamazian G, et al
    Analytical "bake-off" of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis.
    PLoS One. 2018;13:e0200423.
    PubMed     Text format     Abstract available


  81. MIOTTO N, Mendes LC, Zanaga LP, Lazarini MSK, et al
    All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response.
    PLoS One. 2018;13:e0199941.
    PubMed     Text format     Abstract available


  82. MALAGNINO V, Salpini R, Maffongelli G, Battisti A, et al
    High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance.
    PLoS One. 2018;13:e0195045.
    PubMed     Text format     Abstract available


  83. TIEU HV, Laeyendecker O, Nandi V, Rose R, et al
    Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
    PLoS One. 2018;13:e0200269.
    PubMed     Text format     Abstract available


  84. WEI L, Wedemeyer H, Liaw YF, Chan HL, et al
    No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
    PLoS One. 2018;13:e0199198.
    PubMed     Text format     Abstract available


  85. XAYDALASOUK K, Strobel M, Buisson Y, Black AP, et al
    Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories.
    PLoS One. 2018;13:e0199919.
    PubMed     Text format     Abstract available


  86. XIONG QF, Xiong T, Huang P, Zhong YD, et al
    Early predictors of acute hepatitis B progression to liver failure.
    PLoS One. 2018;13:e0201049.
    PubMed     Text format     Abstract available


  87. SOOD A, Suryaprasad A, Trickey A, Kanchi S, et al
    The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey.
    PLoS One. 2018;13:e0200461.
    PubMed     Text format     Abstract available


  88. CUYPERS L, Perez AB, Chueca N, Aldamiz-Echevarria T, et al
    Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.
    PLoS One. 2018;13:e0201268.
    PubMed     Text format     Abstract available


  89. EVANS H, Balasegaram S, Douthwaite S, Hunter L, et al
    An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    PLoS One. 2018;13:e0198520.
    PubMed     Text format     Abstract available


  90. MOTOYAMA H, Tamori A, Kubo S, Uchida-Kobayashi S, et al
    Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    PLoS One. 2018;13:e0201423.
    PubMed     Text format     Abstract available


  91. TAT TRUNG N, Duong DC, Tong HV, Hien TTT, et al
    Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    PLoS One. 2018;13:e0196081.
    PubMed     Text format     Abstract available


  92. EVON DM, Stewart PW, Amador J, Serper M, et al
    A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.
    PLoS One. 2018;13:e0196908.
    PubMed     Text format     Abstract available


  93. NEESGAARD B, Ruhwald M, Krarup HB, Weis N, et al
    Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail.
    PLoS One. 2018;13:e0201629.
    PubMed     Text format     Abstract available


  94. JUN BG, Kim YD, Kim SG, Kim YS, et al
    Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study.
    PLoS One. 2018;13:e0201316.
    PubMed     Text format     Abstract available


  95. ELIZALDE MM, Perez PS, Sevic I, Grasso D, et al
    HBV subgenotypes F1b and F4 replication induces an incomplete autophagic process in hepatocytes: Role of BCP and preCore mutations.
    PLoS One. 2018;13:e0197109.
    PubMed     Text format     Abstract available


  96. MASSAQUOI TA, Burke RM, Yang G, Lakoh S, et al
    Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone.
    PLoS One. 2018;13:e0201820.
    PubMed     Text format     Abstract available


  97. DU Z, Dong J, Bi J, Bai R, et al
    Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
    PLoS One. 2018;13:e0195336.
    PubMed     Text format     Abstract available


  98. POSUWAN N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, et al
    Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    PLoS One. 2018;13:e0202637.
    PubMed     Text format     Abstract available


  99. GOUNTAS I, Sypsa V, Blach S, Razavi H, et al
    HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era.
    PLoS One. 2018;13:e0202109.
    PubMed     Text format     Abstract available


  100. HSIEH YC, Jeng WJ, Huang CH, Teng W, et al
    Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis.
    PLoS One. 2018;13:e0202777.
    PubMed     Text format     Abstract available


  101. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.
    PLoS One. 2018;13:e0202991.
    PubMed     Text format     Abstract available


  102. WHITMILL A, Kim S, Rojas V, Gulraiz F, et al
    Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
    PLoS One. 2018;13:e0202524.
    PubMed     Text format     Abstract available


  103. AL MAHTAB M, Akbar SMF, Aguilar JC, Guillen G, et al
    Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
    PLoS One. 2018;13:e0201236.
    PubMed     Text format     Abstract available


  104. GOYAL A, Romero-Severson EO
    Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.
    PLoS One. 2018;13:e0203831.
    PubMed     Text format     Abstract available


  105. SILVA CMD, Peder LD, Guelere AM, Horvath JD, et al
    Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    PLoS One. 2018;13:e0203272.
    PubMed     Text format     Abstract available


  106. XING YF, Zhou DQ, He JS, Wei CS, et al
    Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    PLoS One. 2018;13:e0203220.
    PubMed     Text format     Abstract available


  107. WANG YW, Shen ZZ, Jiang Y
    Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China.
    PLoS One. 2018;13:e0201987.
    PubMed     Text format     Abstract available


  108. OWUSU M, Bonney JK, Annan AA, Mawuli G, et al
    Aetiology of viral hepatitis among jaundiced patients presenting to a tertiary hospital in Ghana.
    PLoS One. 2018;13:e0203699.
    PubMed     Text format     Abstract available


  109. LUK KC, Coller KE, Dawson GJ, Cloherty GA, et al
    Identification of a putative novel genotype 3/rabbit hepatitis E virus (HEV) recombinant.
    PLoS One. 2018;13:e0203618.
    PubMed     Text format     Abstract available


  110. DAS S, Opoku J, Allston A, Kharfen M, et al
    Detecting spatial clusters of HIV and hepatitis coinfections.
    PLoS One. 2018;13:e0203674.
    PubMed     Text format     Abstract available


  111. KENNEDY K, Graham SM, Arora N, Shuhart MC, et al
    Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
    PLoS One. 2018;13:e0204031.
    PubMed     Text format     Abstract available


  112. ZHANG XS, Iacono GL
    Estimating human-to-human transmissibility of hepatitis A virus in an outbreak at an elementary school in China, 2011.
    PLoS One. 2018;13:e0204201.
    PubMed     Text format     Abstract available


  113. VALENCIA LA ROSA J, Ryan P, Alvaro-Meca A, Troya J, et al
    HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
    PLoS One. 2018;13:e0204795.
    PubMed     Text format     Abstract available


  114. BOTTINO FO, Gardinali NR, Salvador SBS, Figueiredo AS, et al
    Cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with hepatitis E virus: The bone marrow as a possible new viral target.
    PLoS One. 2018;13:e0205039.
    PubMed     Text format     Abstract available


  115. UCHIDA Y, Naiki K, Kouyama JI, Sugawara K, et al
    Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.
    PLoS One. 2018;13:e0205600.
    PubMed     Text format     Abstract available


  116. SOSA-JURADO F, Melendez-Mena D, Rosas-Murrieta NH, Guzman-Flores B, et al
    Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
    PLoS One. 2018;13:e0205356.
    PubMed     Text format     Abstract available


  117. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    PubMed     Text format     Abstract available


  118. JUANBELTZ R, Martinez-Baz I, San Miguel R, Goni-Esarte S, et al
    Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
    PLoS One. 2018;13:e0205277.
    PubMed     Text format     Abstract available


  119. SCHNELL G, Krishnan P, Tripathi R, Beyer J, et al
    Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
    PLoS One. 2018;13:e0205186.
    PubMed     Text format     Abstract available


  120. FAHMY AM, Khabir M, Blanchet M, Labonte P, et al
    LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.
    PLoS One. 2018;13:e0205189.
    PubMed     Text format     Abstract available


  121. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Text format     Abstract available


  122. MCCLURE MW, Berliba E, Tsertsvadze T, Streinu-Cercel A, et al
    Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
    PLoS One. 2018;13:e0204974.
    PubMed     Text format     Abstract available


  123. NISBET AI, Omuse G, Revathi G, Adam RD, et al
    Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica.
    PLoS One. 2018;13:e0204867.
    PubMed     Text format     Abstract available


    January 2017
  124. COUTO I, Victoria M, Veloso VG, Rodrigues L, et al
    Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.
    PLoS One. 2017;12:e0174453.
    PubMed     Text format     Abstract available


  125. GARDINALI NR, Guimaraes JR, Melgaco JG, Kevorkian YB, et al
    Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    PLoS One. 2017;12:e0174070.
    PubMed     Text format     Abstract available


  126. YOSHIOKA T, Tatsumi T, Miyagi T, Mukai K, et al
    Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    PLoS One. 2017;12:e0174103.
    PubMed     Text format     Abstract available


  127. RALLON N, Garcia M, Garcia-Samaniego J, Rodriguez N, et al
    HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    PLoS One. 2017;12:e0173943.
    PubMed     Text format     Abstract available


  128. GUPTA N, Kabahizi J, Mukabatsinda C, Walker TD, et al
    "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
    PLoS One. 2017;12:e0174148.
    PubMed     Text format     Abstract available


  129. GUINOISEAU T, Moreau A, Hohnadel G, Ngo-Giang-Huong N, et al
    Deep sequencing is an appropriate tool for the selection of unique Hepatitis C virus (HCV) variants after single genomic amplification.
    PLoS One. 2017;12:e0174852.
    PubMed     Text format     Abstract available


  130. HUANG YJ, Chang CS, Peng YC, Yeh HZ, et al
    On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.
    PLoS One. 2017;12:e0174046.
    PubMed     Text format     Abstract available


  131. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0174544.
    PubMed     Text format     Abstract available


  132. CHEN HC, Chung CH, Wang CH, Lin JC, et al
    Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.
    PLoS One. 2017;12:e0175266.
    PubMed     Text format     Abstract available


  133. YE Q, Yin W, Zhang L, Xiao H, et al
    The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.
    PLoS One. 2017;12:e0175165.
    PubMed     Text format     Abstract available


  134. KACZMAREK DJ, Kokordelis P, Kramer B, Glassner A, et al
    Alterations of the NK cell pool in HIV/HCV co-infection.
    PLoS One. 2017;12:e0174465.
    PubMed     Text format     Abstract available


  135. CHEN H, Chen L
    Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China.
    PLoS One. 2017;12:e0175189.
    PubMed     Text format     Abstract available


  136. KOMOLMIT P, Charoensuk K, Thanapirom K, Suksawatamnuay S, et al
    Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
    PLoS One. 2017;12:e0174608.
    PubMed     Text format     Abstract available


  137. FERNANDEZ-CABALLERO JA, Alvarez M, Chueca N, Perez AB, et al
    The cobas(R) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.
    PLoS One. 2017;12:e0175564.
    PubMed     Text format     Abstract available


  138. YANG CM, Yoon JC, Park JH, Lee JM, et al
    Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    PLoS One. 2017;12:e0175793.
    PubMed     Text format     Abstract available


  139. CHLIBEK R, Smetana J, Sosovickova R, Gal P, et al
    Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.
    PLoS One. 2017;12:e0175525.
    PubMed     Text format     Abstract available


  140. NGUYEN HM, Sy BT, Trung NT, Hoan NX, et al
    Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.
    PLoS One. 2017;12:e0175304.
    PubMed     Text format     Abstract available


  141. DU H, Yang J, Bai J, Ming K, et al
    A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type 1.
    PLoS One. 2017;12:e0175495.
    PubMed     Text format     Abstract available


  142. LE GUILLOU-GUILLEMETTE H, Pivert A, Bouthry E, Henquell C, et al
    Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0174651.
    PubMed     Text format     Abstract available


  143. FAN Z, EnQiang C, Yao DL, LiBo Y, et al
    Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system.
    PLoS One. 2017;12:e0175332.
    PubMed     Text format     Abstract available


  144. NEFFATTI H, Lebraud P, Hottelet C, Gharbi J, et al
    Southern Tunisia: A still high endemicity area for hepatitis A.
    PLoS One. 2017;12:e0175887.
    PubMed     Text format     Abstract available


  145. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Text format     Abstract available


  146. CAPILENO YA, Van den Bergh R, Donchunk D, Hinderaker SG, et al
    Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    PLoS One. 2017;12:e0175562.
    PubMed     Text format     Abstract available


  147. SLOT E, Zaaijer HL, Molier M, Van den Hurk K, et al
    Meat consumption is a major risk factor for hepatitis E virus infection.
    PLoS One. 2017;12:e0176414.
    PubMed     Text format     Abstract available


  148. PENE V, Lemasson M, Harper F, Pierron G, et al
    Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis.
    PLoS One. 2017;12:e0175810.
    PubMed     Text format     Abstract available


  149. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  150. FRIAS M, Rivero-Juarez A, Tellez F, Perez-Perez M, et al
    Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.
    PLoS One. 2017;12:e0177141.
    PubMed     Text format     Abstract available


  151. GENCAY M, Hubner K, Gohl P, Seffner A, et al
    Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.
    PLoS One. 2017;12:e0172101.
    PubMed     Text format     Abstract available


  152. MOQUEET N, Kanagaratham C, Gill MJ, Hull M, et al
    A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
    PLoS One. 2017;12:e0176282.
    PubMed     Text format     Abstract available


  153. DIRKSEN K, Spee B, Penning LC, van den Ingh TSGAM, et al
    Gene expression patterns in the progression of canine copper-associated chronic hepatitis.
    PLoS One. 2017;12:e0176826.
    PubMed     Text format     Abstract available


  154. SUN J, Robinson L, Lee NL, Welles S, et al
    No contribution of lifestyle and environmental exposures to gender discrepancy of liver disease severity in chronic hepatitis b infection: Observations from the Haimen City cohort.
    PLoS One. 2017;12:e0175482.
    PubMed     Text format     Abstract available


  155. BIRGER RB, Le T, Kouyos RD, Grenfell BT, et al
    The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
    PLoS One. 2017;12:e0177195.
    PubMed     Text format     Abstract available


  156. PANDOLFI R, Ramos de Almeida D, Alves Pinto M, Kreutz LC, et al
    In house ELISA based on recombinant ORF2 protein underline high prevalence of IgG anti-hepatitis E virus amongst blood donors in south Brazil.
    PLoS One. 2017;12:e0176409.
    PubMed     Text format     Abstract available


  157. CHANG CC, Hsu HJ, Yen JH, Lo SY, et al
    A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.
    PLoS One. 2017;12:e0177383.
    PubMed     Text format     Abstract available


  158. NAKAMURA M, Kanda T, Jiang X, Haga Y, et al
    Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    PLoS One. 2017;12:e0177302.
    PubMed     Text format     Abstract available


  159. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
    PLoS One. 2017;12:e0177022.
    PubMed     Text format     Abstract available


  160. BAEZ PA, Lopez MC, Duque-Jaramillo A, Pelaez D, et al
    First evidence of the Hepatitis E virus in environmental waters in Colombia.
    PLoS One. 2017;12:e0177525.
    PubMed     Text format     Abstract available


  161. D'ARMINIO MONFORTE A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, et al
    Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
    PLoS One. 2017;12:e0177402.
    PubMed     Text format     Abstract available


  162. AGGARWAL R, Chen Q, Goel A, Seguy N, et al
    Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
    PLoS One. 2017;12:e0176503.
    PubMed     Text format     Abstract available


  163. CENTO V, Nguyen THT, Di Carlo D, Biliotti E, et al
    Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
    PLoS One. 2017;12:e0177352.
    PubMed     Text format     Abstract available


  164. ECKHARDT B, Winkelstein ER, Shu MA, Carden MR, et al
    Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
    PLoS One. 2017;12:e0177341.
    PubMed     Text format     Abstract available


  165. JANG Y, Kim JH, Lee K
    Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B.
    PLoS One. 2017;12:e0177690.
    PubMed     Text format     Abstract available


  166. HAN Z, Yin Y, Zhang Y, Ehrhardt S, et al
    Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China.
    PLoS One. 2017;12:e0178671.
    PubMed     Text format     Abstract available


  167. HUNDIE GB, Raj VS, GebreMichael D, Pas SD, et al
    Genetic diversity of hepatitis C virus in Ethiopia.
    PLoS One. 2017;12:e0179064.
    PubMed     Text format     Abstract available


  168. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0179070.
    PubMed     Text format     Abstract available


  169. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Text format     Abstract available


  170. NAIK AS, Owsianka A, Palmer BA, O'Halloran CJ, et al
    Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.
    PLoS One. 2017;12:e0175349.
    PubMed     Text format     Abstract available


  171. EL HADAD S, Al-Hamdan H, Linjawi S
    Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia.
    PLoS One. 2017;12:e0178225.
    PubMed     Text format     Abstract available


  172. JANG TY, Lin PC, Huang CI, Liao YM, et al
    Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
    PLoS One. 2017;12:e0178883.
    PubMed     Text format     Abstract available


  173. TAUBERT R, Hardtke-Wolenski M, Noyan F, Lalanne C, et al
    Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.
    PLoS One. 2017;12:e0179074.
    PubMed     Text format     Abstract available


  174. CHIU NC, Su CW, Liu CA, Huang YH, et al
    Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infections.
    PLoS One. 2017;12:e0178841.
    PubMed     Text format     Abstract available


  175. SAHA D, Pal A, Sarkar N, Das D, et al
    Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India.
    PLoS One. 2017;12:e0179035.
    PubMed     Text format     Abstract available


  176. HARRIS BJ, Holzmayer V, Qureshi H, Khan MA, et al
    Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors.
    PLoS One. 2017;12:e0178988.
    PubMed     Text format     Abstract available


  177. ALVARO-MECA A, Berenguer J, Diaz A, Micheloud D, et al
    Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.
    PLoS One. 2017;12:e0179493.
    PubMed     Text format     Abstract available


  178. CHU PS, Nakamoto N, Taniki N, Ojiro K, et al
    On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
    PLoS One. 2017;12:e0179096.
    PubMed     Text format     Abstract available


  179. NDOW G, Gore ML, Shimakawa Y, Suso P, et al
    Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
    PLoS One. 2017;12:e0179025.
    PubMed     Text format     Abstract available


  180. LEE JW, Kim W, Kwon EK, Kim Y, et al
    Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
    PLoS One. 2017;12:e0179094.
    PubMed     Text format     Abstract available


  181. CHENG ST, Tang H, Ren JH, Chen X, et al
    Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
    PLoS One. 2017;12:e0179605.
    PubMed     Text format     Abstract available


  182. OU X, Mao S, Cao J, Cheng A, et al
    Comparative analysis of virus-host interactions caused by a virulent and an attenuated duck hepatitis A virus genotype 1.
    PLoS One. 2017;12:e0178993.
    PubMed     Text format     Abstract available


  183. WU YT, Li X, Liu ZL, Xu Z, et al
    Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179680.
    PubMed     Text format     Abstract available


  184. CAPILENO YA, Van den Bergh R, Donchuk D, Hinderaker SG, et al
    Correction: Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    PLoS One. 2017;12:e0180286.
    PubMed     Text format     Abstract available


  185. MASCIA C, Vita S, Zuccala P, Marocco R, et al
    Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.
    PLoS One. 2017;12:e0179400.
    PubMed     Text format     Abstract available


  186. ELSHERIF O, Bannan C, Keating S, McKiernan S, et al
    Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.
    PLoS One. 2017;12:e0178398.
    PubMed     Text format     Abstract available


  187. GUILLOT C, Martel N, Berby F, Bordes I, et al
    Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
    PLoS One. 2017;12:e0179697.
    PubMed     Text format     Abstract available


  188. LIN HC, Xirasagar S, Lee HC, Huang CC, et al
    Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
    PLoS One. 2017;12:e0179312.
    PubMed     Text format     Abstract available


  189. LIU Z, Li S, Liu Y, Guo W, et al
    PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.
    PLoS One. 2017;12:e0180390.
    PubMed     Text format     Abstract available


  190. ISHIZAKI A, Tran VT, Nguyen CH, Tanimoto T, et al
    Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.
    PLoS One. 2017;12:e0179616.
    PubMed     Text format     Abstract available


  191. LIU T, Wang F, Zhang S, Wang F, et al
    Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China.
    PLoS One. 2017;12:e0179846.
    PubMed     Text format     Abstract available


  192. BELAUNZARAN-ZAMUDIO PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, et al
    Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    PLoS One. 2017;12:e0179931.
    PubMed     Text format     Abstract available


  193. ABEBE M, Ali I, Ayele S, Overbo J, et al
    Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0180078.
    PubMed     Text format     Abstract available


  194. SHIU TY, Huang SM, Shih YL, Chu HC, et al
    Correction: Hepatitis C Virus Core Protein Down-Regulates p21Waf1/Cip1 and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells.
    PLoS One. 2017;12:e0181299.
    PubMed     Text format     Abstract available


  195. SNOW KJ, Richards AH, Kinner SA
    Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort study.
    PLoS One. 2017;12:e0180646.
    PubMed     Text format     Abstract available


  196. RENDON JC, Cortes-Mancera F, Restrepo-Gutierrez JC, Hoyos S, et al
    Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.
    PLoS One. 2017;12:e0180447.
    PubMed     Text format     Abstract available


  197. LEVENTER-ROBERTS M, Hammerman A, Brufman I, Hoshen M, et al
    Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.
    PLoS One. 2017;12:e0176858.
    PubMed     Text format     Abstract available


  198. JANG YR, Shin Y, Jin CE, Koo B, et al
    Molecular detection of Coxiella burnetii from the formalin-fixed tissues of Q fever patients with acute hepatitis.
    PLoS One. 2017;12:e0180237.
    PubMed     Text format     Abstract available


  199. LOPEZ-RODRIGUEZ R, Hernandez-Bartolome A, Borque MJ, Rodriguez-Munoz Y, et al
    Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C.
    PLoS One. 2017;12:e0180927.
    PubMed     Text format     Abstract available


  200. DALGARD O, Weiland O, Noraberg G, Karlsen L, et al
    Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.
    PLoS One. 2017;12:e0179764.
    PubMed     Text format     Abstract available


  201. DIESTELHORST J, Junge N, Schlue J, Falk CS, et al
    Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    PLoS One. 2017;12:e0181107.
    PubMed     Text format     Abstract available


  202. ANDRE-GARNIER E, Besse B, Rodallec A, Ribeyrol O, et al
    An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.
    PLoS One. 2017;12:e0179562.
    PubMed     Text format     Abstract available


  203. NEUKAM K, Martinez AP, Culasso ACA, Ridruejo E, et al
    NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.
    PLoS One. 2017;12:e0182193.
    PubMed     Text format     Abstract available


  204. MATSUO J, Do SH, Yamamoto C, Nagashima S, et al
    Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family.
    PLoS One. 2017;12:e0177248.
    PubMed     Text format     Abstract available


  205. RUSSELLI G, Pizzillo P, Iannolo G, Barbera F, et al
    HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.
    PLoS One. 2017;12:e0181683.
    PubMed     Text format     Abstract available


  206. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Text format     Abstract available


  207. MERDAN M, Bekiryazici Z, Kesemen T, Khaniyev T, et al
    Deterministic stability and random behavior of a Hepatitis C model.
    PLoS One. 2017;12:e0181571.
    PubMed     Text format     Abstract available


  208. STELZL E, Haas B, Bauer B, Zhang S, et al
    First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing.
    PLoS One. 2017;12:e0181273.
    PubMed     Text format     Abstract available


  209. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Text format     Abstract available


  210. TAN WG, Zubkova I, Kachko A, Wells F, et al
    Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    PLoS One. 2017;12:e0181578.
    PubMed     Text format     Abstract available


  211. HUGHES MG JR, Tucker WW, Reddy S, Brier ME, et al
    Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.
    PLoS One. 2017;12:e0180719.
    PubMed     Text format     Abstract available


  212. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Text format     Abstract available


  213. GOUVEIA LR, Santos JC, Silva RD, Batista AD, et al
    Diagnosis of coinfection by schistosomiasis and viral hepatitis B or C using 1H NMR-based metabonomics.
    PLoS One. 2017;12:e0182196.
    PubMed     Text format     Abstract available


  214. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
    PLoS One. 2017;12:e0181890.
    PubMed     Text format     Abstract available


  215. NAGAOKI Y, Imamura M, Aikata H, Daijo K, et al
    The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
    PLoS One. 2017;12:e0182710.
    PubMed     Text format     Abstract available


  216. KIM YA, Trinh S, Thura S, Kyi KP, et al
    Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
    PLoS One. 2017;12:e0181603.
    PubMed     Text format     Abstract available


  217. HUANG CM, Chang KC, Hung CH, Chiu KW, et al
    Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
    PLoS One. 2017;12:e0182204.
    PubMed     Text format     Abstract available


  218. WISSKIRCHEN K, Metzger K, Schreiber S, Asen T, et al
    Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
    PLoS One. 2017;12:e0182936.
    PubMed     Text format     Abstract available


  219. GOSSELIN A, Lelievre E, Ravalihasy A, Lydie N, et al
    "Times Are Changing": The Impact of HIV Diagnosis on Sub-Saharan Migrants' Lives in France.
    PLoS One. 2017;12:e0170226.
    PubMed     Text format     Abstract available


  220. WU CK, Liang CM, Hsu CN, Hung TH, et al
    The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    PLoS One. 2017;12:e0169884.
    PubMed     Text format     Abstract available


  221. NIU C, Livingston CM, Li L, Beran RK, et al
    The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection.
    PLoS One. 2017;12:e0169648.
    PubMed     Text format     Abstract available


  222. LIU X, He L, Han J, Wang L, et al
    Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    PLoS One. 2017;12:e0170605.
    PubMed     Text format     Abstract available


  223. CHO YE, Im EJ, Moon PG, Mezey E, et al
    Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    PLoS One. 2017;12:e0172463.
    PubMed     Text format     Abstract available


  224. DE WEGGHELEIRE A, An S, De Baetselier I, Soeung P, et al
    A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.
    PLoS One. 2017;12:e0183530.
    PubMed     Text format     Abstract available


  225. BUTT ZA, Shrestha N, Wong S, Kuo M, et al
    A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
    PLoS One. 2017;12:e0183609.
    PubMed     Text format     Abstract available


  226. GUO G, Zhang L, Ye S, Hu Y, et al
    Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.
    PLoS One. 2017;12:e0171959.
    PubMed     Text format     Abstract available


  227. CARRIERI MP, Marcellin F, Fressard L, Preau M, et al
    Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey).
    PLoS One. 2017;12:e0171645.
    PubMed     Text format     Abstract available


  228. MANICKAM C, Wachtman L, Martinot AJ, Giavedoni LD, et al
    Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).
    PLoS One. 2017;12:e0170240.
    PubMed     Text format     Abstract available


  229. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    PubMed     Text format     Abstract available


  230. SHIER MK, Iles JC, El-Wetidy MS, Ali HH, et al
    Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
    PLoS One. 2017;12:e0184163.
    PubMed     Text format     Abstract available


  231. HERMETET C, Dubois F, Gaudy-Graffin C, Bacq Y, et al
    Continuum of hepatitis C care in France: A 20-year cohort study.
    PLoS One. 2017;12:e0183232.
    PubMed     Text format     Abstract available


  232. KJAERGAARD M, Thiele M, Jansen C, Staehr Madsen B, et al
    High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.
    PLoS One. 2017;12:e0173992.
    PubMed     Text format     Abstract available


  233. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    PubMed     Text format     Abstract available


  234. ZHENG Z, Sze CW, Keng CT, Al-Haddawi M, et al
    Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.
    PLoS One. 2017;12:e0184127.
    PubMed     Text format     Abstract available


  235. DAVIES J, Li SQ, Tong SY, Baird RW, et al
    Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.
    PLoS One. 2017;12:e0184082.
    PubMed     Text format     Abstract available


  236. GOMEZ-MORENO AZ, Pineda-Tenor D, Jimenez-Sousa MA, Sanchez-Ruano JJ, et al
    Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
    PLoS One. 2017;12:e0184404.
    PubMed     Text format     Abstract available


  237. VUTIEN P, Jin M, Le MH, Nguyen P, et al
    Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
    PLoS One. 2017;12:e0183851.
    PubMed     Text format     Abstract available


  238. WANG L, Cao M, Wei QL, Zhao ZH, et al
    A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
    PLoS One. 2017;12:e0175992.
    PubMed     Text format     Abstract available


  239. GONZALEZ R, De la Rosa AJ, Rufini A, Rodriguez-Hernandez MA, et al
    Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    PLoS One. 2017;12:e0174326.
    PubMed     Text format     Abstract available


  240. KEATING SM, Dodge JL, Norris PJ, Heitman J, et al
    The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    PLoS One. 2017;12:e0181004.
    PubMed     Text format     Abstract available


  241. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    PLoS One. 2017;12:e0184550.
    PubMed     Text format     Abstract available


  242. TUDESQ JJ, Dunyach-Remy C, Combescure C, Doncesco R, et al
    Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
    PLoS One. 2017;12:e0183372.
    PubMed     Text format     Abstract available


  243. ROSINSKA M, Parda N, Kolakowska A, Godzik P, et al
    Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016.
    PLoS One. 2017;12:e0185055.
    PubMed     Text format     Abstract available


  244. UITTE DE WILLIGE S, Keane FM, Bowen DG, Malfliet JJMC, et al
    Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease.
    PLoS One. 2017;12:e0178987.
    PubMed     Text format     Abstract available


  245. KRAUSKOPF J, de Kok TM, Schomaker SJ, Gosink M, et al
    Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    PLoS One. 2017;12:e0177928.
    PubMed     Text format     Abstract available


  246. WANG H, Zhang W, Gu H, Chen W, et al
    Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein.
    PLoS One. 2017;12:e0184947.
    PubMed     Text format     Abstract available


  247. HOU J, Brouwer WP, Kreefft K, Gama L, et al
    Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.
    PLoS One. 2017;12:e0179920.
    PubMed     Text format     Abstract available


  248. GONZALES-GUSTAVSON E, Timoneda N, Fernandez-Cassi X, Caballero A, et al
    Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology.
    PLoS One. 2017;12:e0185911.
    PubMed     Text format     Abstract available


  249. NAGATY A, Abd El-Wahab EW
    Real-life results of sofosbuvir based therapy in chronic hepatitis C -naive and -experienced patients in Egypt.
    PLoS One. 2017;12:e0184654.
    PubMed     Text format     Abstract available


  250. NOSAKA T, Naito T, Hiramatsu K, Ohtani M, et al
    Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.
    PLoS One. 2017;12:e0185442.
    PubMed     Text format     Abstract available


  251. YANG CK, Wang XK, Liao XW, Han CY, et al
    Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
    PLoS One. 2017;12:e0182208.
    PubMed     Text format     Abstract available


  252. BIADGO B, Shiferaw E, Woldu B, Alene KA, et al
    Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.
    PLoS One. 2017;12:e0180416.
    PubMed     Text format     Abstract available


  253. PARASCHIV S, Banica L, Nicolae I, Niculescu I, et al
    Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.
    PLoS One. 2017;12:e0185866.
    PubMed     Text format     Abstract available


  254. JARAMILLO CM, de La Hoz F, Porras A, di Filippo D, et al
    Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.
    PLoS One. 2017;12:e0181643.
    PubMed     Text format     Abstract available


  255. CHAMBAL LM, Samo Gudo E, Carimo A, Corte Real R, et al
    HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    PLoS One. 2017;12:e0181836.
    PubMed     Text format     Abstract available


  256. VAN LOO IHM, Dukers-Muijrers NHTM, Heuts R, van der Sande MAB, et al
    Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling.
    PLoS One. 2017;12:e0186722.
    PubMed     Text format     Abstract available


  257. UEMURA H, Tsukada K, Mizushima D, Aoki T, et al
    Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    PLoS One. 2017;12:e0186255.
    PubMed     Text format     Abstract available


  258. BURCHILL MA, Roby JA, Crochet N, Wind-Rotolo M, et al
    Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.
    PLoS One. 2017;12:e0186213.
    PubMed     Text format     Abstract available


  259. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Text format     Abstract available


  260. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Text format     Abstract available


  261. LI T, Gao Y, Dong Q, Wang H, et al
    Degree sums and dense spanning trees.
    PLoS One. 2017;12:e0184912.
    PubMed     Text format     Abstract available


  262. DUFFY D, Mottez E, Ainsworth S, Buivan TP, et al
    An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms.
    PLoS One. 2017;12:e0183084.
    PubMed     Text format     Abstract available


  263. LUBYOVA B, Hodek J, Zabransky A, Prouzova H, et al
    PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.
    PLoS One. 2017;12:e0186982.
    PubMed     Text format     Abstract available


  264. CHEN YI MEI SLG, Thompson AJ, Christensen B, Cunningham G, et al
    Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
    PLoS One. 2017;12:e0185609.
    PubMed     Text format     Abstract available


  265. YOON JG, Choi MJ, Yoon JW, Noh JY, et al
    Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea.
    PLoS One. 2017;12:e0186257.
    PubMed     Text format     Abstract available


  266. PALIWAL D, Joshi P, Panda SK
    Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR.
    PLoS One. 2017;12:e0187334.
    PubMed     Text format     Abstract available


  267. OKA S, Furukawa H, Yasunami M, Kawasaki A, et al
    HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
    PLoS One. 2017;12:e0187325.
    PubMed     Text format     Abstract available


  268. DULTZ G, Graubard BI, Martin P, Welker MW, et al
    Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.
    PLoS One. 2017;12:e0186898.
    PubMed     Text format     Abstract available


  269. HARFOUCHE M, Chemaitelly H, Kouyoumjian SP, Mahmud S, et al
    Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.
    PLoS One. 2017;12:e0187177.
    PubMed     Text format     Abstract available


  270. ROZERA G, Fabbri G, Lorenzini P, Mastrorosa I, et al
    Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals.
    PLoS One. 2017;12:e0187095.
    PubMed     Text format     Abstract available


  271. MAROT A, Henrion J, Knebel JF, Moreno C, et al
    Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    PLoS One. 2017;12:e0186715.
    PubMed     Text format     Abstract available


  272. KONDILI LA, Gaeta GB, Brunetto MR, Di Leo A, et al
    Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
    PLoS One. 2017;12:e0185728.
    PubMed     Text format     Abstract available


  273. LOGGI E, Galli S, Vitale G, Di Donato R, et al
    Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.
    PLoS One. 2017;12:e0187755.
    PubMed     Text format     Abstract available


  274. LANINI S, Minosse C, Vairo F, Garbuglia A, et al
    A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017.
    PLoS One. 2017;12:e0185428.
    PubMed     Text format     Abstract available


  275. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Text format     Abstract available


  276. YANG Z, Jia M, Liu G, Hao H, et al
    Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
    PLoS One. 2017;12:e0187551.
    PubMed     Text format     Abstract available


  277. RISALDE MA, Rivero-Juarez A, Romero-Palomo F, Frias M, et al
    Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar.
    PLoS One. 2017;12:e0186858.
    PubMed     Text format     Abstract available


  278. KONERMAN MA, Lu D, Zhang Y, Thomson M, et al
    Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.
    PLoS One. 2017;12:e0187344.
    PubMed     Text format     Abstract available


  279. XIAO H, Shi M, Xie Y, Chi X, et al
    Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186660.
    PubMed     Text format     Abstract available


  280. YINDOM LM, Mendy M, Bodimeade C, Chambion C, et al
    KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
    PLoS One. 2017;12:e0188307.
    PubMed     Text format     Abstract available


  281. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Text format     Abstract available


  282. SHIMIZU JF, Pereira CM, Bittar C, Batista MN, et al
    Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle.
    PLoS One. 2017;12:e0187857.
    PubMed     Text format     Abstract available


  283. STROFFOLINI T, Sagnelli E, Andriulli A, Colloredo G, et al
    Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.
    PLoS One. 2017;12:e0185710.
    PubMed     Text format     Abstract available


  284. GARRIGA C, Manzanares-Laya S, Garcia de Olalla P, Gorrindo P, et al
    Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.
    PLoS One. 2017;12:e0187893.
    PubMed     Text format     Abstract available


  285. CARLUCCI JG, Farooq SA, Sizemore L, Rickles M, et al
    Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
    PLoS One. 2017;12:e0188624.
    PubMed     Text format     Abstract available


  286. BRAGA ACS, Carneiro BM, Batista MN, Akinaga MM, et al
    Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity.
    PLoS One. 2017;12:e0188467.
    PubMed     Text format     Abstract available


  287. SPINA A, Lenglet A, Beversluis D, de Jong M, et al
    A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017.
    PLoS One. 2017;12:e0188240.
    PubMed     Text format     Abstract available


  288. LEE IC, Chau GY, Yeh YC, Chao Y, et al
    Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.
    PLoS One. 2017;12:e0188552.
    PubMed     Text format     Abstract available


  289. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Text format     Abstract available


  290. MUNSHI SU, Tran TTT, Vo TNT, Tabassum S, et al
    Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population.
    PLoS One. 2017;12:e0188944.
    PubMed     Text format     Abstract available


  291. CANGELOSI Q, Means SA, Ho H
    A multi-scale spatial model of hepatitis-B viral dynamics.
    PLoS One. 2017;12:e0188209.
    PubMed     Text format     Abstract available


  292. CANINI L, Imamura M, Kawakami Y, Uprichard SL, et al
    HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.
    PLoS One. 2017;12:e0187409.
    PubMed     Text format     Abstract available


  293. SMITH JW, Kroker-Lobos MF, Lazo M, Rivera-Andrade A, et al
    Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.
    PLoS One. 2017;12:e0189255.
    PubMed     Text format     Abstract available


  294. COMSTOCK E, Kim CW, Murphy A, Emmanuel B, et al
    Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.
    PLoS One. 2017;12:e0188314.
    PubMed     Text format     Abstract available


  295. YIN F, Xie Y, Fan H, Zhang J, et al
    Mutations in hepatitis B virus polymerase are associated with the postoperative survival of hepatocellular carcinoma patients.
    PLoS One. 2017;12:e0189730.
    PubMed     Text format     Abstract available


  296. PANNETIER J, Gigonzac V, Lydie N, Desgrees du Lou A, et al
    Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France.
    PLoS One. 2017;12:e0189196.
    PubMed     Text format     Abstract available


  297. DERESSA T, Damtie D, Fonseca K, Gao S, et al
    The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    PLoS One. 2017;12:e0190149.
    PubMed     Text format     Abstract available


  298. BROQUETAS T, Garcia-Retortillo M, Hernandez JJ, Puigvehi M, et al
    Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
    PLoS One. 2017;12:e0188303.
    PubMed     Text format     Abstract available


  299. LAY P, An S, Soeung S, Srey PS, et al
    Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes.
    PLoS One. 2017;12:e0185348.
    PubMed     Text format     Abstract available


    January 2016
  300. YASUI Y, Abe T, Kurosaki M, Higuchi M, et al
    Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0154558.
    PubMed     Text format     Abstract available


  301. BOCHAROV G, Meyerhans A, Bessonov N, Trofimchuk S, et al
    Spatiotemporal Dynamics of Virus Infection Spreading in Tissues.
    PLoS One. 2016;11:e0168576.
    PubMed     Text format     Abstract available


  302. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Jimenez-Garcia R, Puente-Maestu L, et al
    Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012).
    PLoS One. 2016;11:e0166421.
    PubMed     Text format     Abstract available


  303. NJOKU OS, Manak MM, O'Connell RJ, Shutt AL, et al
    An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.
    PLoS One. 2016;11:e0166711.
    PubMed     Text format     Abstract available


  304. LIMA K, de Souza Leal E, Cavalcanti AM, Salustiano DM, et al
    Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.
    PLoS One. 2016;11:e0155854.
    PubMed     Text format     Abstract available


  305. BRUDER COSTA J, Dufeu-Duchesne T, Leroy V, Bertucci I, et al
    Pegylated Interferon alpha-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    PLoS One. 2016;11:e0158297.
    PubMed     Text format     Abstract available


  306. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Text format     Abstract available


  307. FARSHADPOUR F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, et al
    Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    PLoS One. 2016;11:e0157615.
    PubMed     Text format     Abstract available


  308. WU H, Padhi A, Xu J, Gong X, et al
    Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected Subjects.
    PLoS One. 2016;11:e0161880.
    PubMed     Text format     Abstract available


  309. O'DONNELL PE, Ye XZ, DeChellis MA, Davis VM, et al
    Lipodystrophy, Diabetes and Normal Serum Insulin in PPARgamma-Deficient Neonatal Mice.
    PLoS One. 2016;11:e0160636.
    PubMed     Text format     Abstract available


  310. REMIS RS, Liu J, Loutfy MR, Tharao W, et al
    Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
    PLoS One. 2016;11:e0158090.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: